Comparison of automated subcutaneous defibrillator screening between different pacing sites in cardiac pacing device carriers
Europace · 2023
DOI: 10.1093/europace/euad352 ↗Kurz gefasst
Leserbrief in der Zeitschrift Europace, 2023. Verfasst von Manuel Molina-Lerma und 6 weiteren Autor:innen. Beteiligte Einrichtung: Arrhythmia Unit, Hospital Universitario Virgen de las Nieves, Avenida de las Fuerzas Armadas, 18014 Granada, Spain. Hauptthemen laut MEDLINE: Defibrillators, Implantable, Pacemaker, Artificial, Cardiac Resynchronization Therapy. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 9 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Aims
The compatibility of cardiac pacing with the presence of a subcutaneous implantable cardioverter-defibrillator (S-ICD) has been investigated, but S-ICD screening test results have not been compared among different pacing sites. The objective was to compare S-ICD screening results among different cardiac pacing sites and to assess the electrocardiographic predictors of success. Methods and results This prospective single-centre study conducted automated S-ICD screening in 102 carriers of cardiac pacing devices in conduction system (CSP), biventricular (BVP), right ventricular outflow tract (RVOT), or right ventricular apex (RVA) pacing sites. The study included 102 patients: 40 with CSP (20 left bundle pacing and 20 His bundle pacing), 21 with BVP, and 20 and 21 with RVOT and RVA pacing, respectively. The percentage of positive screenings was significantly higher for CSP (97.5%) than for the other patient groups (BVP 71.4%, RVOT 70%, and RVA 19%). In multivariate analysis, positive screening was associated with a narrower QRS (OR 0.95 [0.92–0.98] P = 0.001) and higher R/T ratio in precordial leads (1.76 [1.18–2.61]).
Conclusion
A higher S-ICD eligibility rate of cardiac pacing device carriers was obtained in CSP than in conventional pacing (RVA or RVOT) or BVP. The presence of narrower paced QRS width and paced corrected QT interval and of higher R/T ratio in precordial and limb leads are electrocardiographic predictors of a positive response to screening.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Arrhythmia Unit, Hospital Universitario Virgen de las Nieves, Avenida de las Fuerzas Armadas, 18014 Granada, Spain.
- Biohealth Research Institute ibs. GRANADA, Av. de Madrid, 15, 18012 Granada, Spain.
ORCID-Profile: Manuel Molina-Lerma, Eva Cabrera-Borrego, Ricardo Rivera-Lopez, Pablo Sánchez-Millán, Jesús Peña Mellado, Antonio Arriaga Jiménez, Miguel Álvarez
Zitieren
APA
Molina-Lerma, M., Cabrera-Borrego, E., Rivera-Lopez, R., Sánchez-Millán, P., Peña Mellado, J., Arriaga Jiménez, A., & Álvarez, M. (2023). Comparison of automated subcutaneous defibrillator screening between different pacing sites in cardiac pacing device carriers. Europace. https://doi.org/10.1093/europace/euad352
Vancouver
Molina-Lerma M, Cabrera-Borrego E, Rivera-Lopez R, Sánchez-Millán P, Peña Mellado J, Arriaga Jiménez A, et al. Comparison of automated subcutaneous defibrillator screening between different pacing sites in cardiac pacing device carriers. Europace. 2023. doi:10.1093/europace/euad352
BibTeX
@article{MolinaLerma2023,
author = {Molina-Lerma, Manuel and Cabrera-Borrego, Eva and Rivera-Lopez, Ricardo and Sánchez-Millán, Pablo and Peña Mellado, Jesús and Arriaga Jiménez, Antonio and Álvarez, Miguel},
title = {Comparison of automated subcutaneous defibrillator screening between different pacing sites in cardiac pacing device carriers},
journal = {Europace},
year = {2023},
doi = {10.1093/europace/euad352}
}
EUVIMED